Lisata Therapeutics
LSTA
52 hedge funds and large institutions have $9.14M invested in Lisata Therapeutics in 2015 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 9 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% more funds holding
Funds holding: 50 → 52 (+2)
33% less capital invested
Capital invested by funds: $13.6M → $9.14M (-$4.45M)
57% less call options, than puts
Call options by funds: $109K | Put options by funds: $255K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$223K |
| 2 |
OC
Oppenheimer & Co
New York
|
+$207K |
| 3 |
State Street
Boston,
Massachusetts
|
+$175K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$162K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$349K |
| 2 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$307K |
| 3 |
Millennium Management
New York
|
-$258K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$250K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$226K |
LSTA Hedge Fund Activity: Q1 2015 in Review
52 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2015, worth a combined $9.14M — down 33% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LSTA positions and 9 closed out — a net gain of 2 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Vanguard Group, adding an estimated $223K. The largest seller was Group One Trading, cutting an estimated $349K.
- 52 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2015, up from 50 in Q4 2014.
- Funds reported $9.14M of Lisata Therapeutics stock for Q1 2015, down 33% quarter-over-quarter.
- 11 funds opened new Lisata Therapeutics positions in Q1 2015 and 9 closed out, a net change of +2 holders.
- The largest Lisata Therapeutics buyer in Q1 2015 was Vanguard Group, an estimated $223K added.
- The largest Lisata Therapeutics seller in Q1 2015 was Group One Trading, an estimated $349K sold.
Based on aggregated 13F filings for Q1 2015.